Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

200 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Melphalan-flufenamide is cytotoxic and potentiates treatment with chemotherapy and the Src inhibitor dasatinib in urothelial carcinoma.
Viktorsson K, Shah CH, Juntti T, Hååg P, Zielinska-Chomej K, Sierakowiak A, Holmsten K, Tu J, Spira J, Kanter L, Lewensohn R, Ullén A. Viktorsson K, et al. Among authors: lewensohn r. Mol Oncol. 2016 May;10(5):719-34. doi: 10.1016/j.molonc.2015.12.013. Epub 2016 Jan 2. Mol Oncol. 2016. PMID: 26827254 Free PMC article.
Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.
Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JA, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L, Lewensohn R. Baumann P, et al. Among authors: lewensohn r. J Clin Oncol. 2009 Jul 10;27(20):3290-6. doi: 10.1200/JCO.2008.21.5681. Epub 2009 May 4. J Clin Oncol. 2009. PMID: 19414667 Clinical Trial.
Apoptotic signaling pathways in lung cancer.
Viktorsson K, Lewensohn R. Viktorsson K, et al. Among authors: lewensohn r. J Thorac Oncol. 2007 Mar;2(3):175-9. doi: 10.1097/JTO.0b013e318031cd78. J Thorac Oncol. 2007. PMID: 17410039 No abstract available.
200 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page